Neeta Somaiah, MD, discusses the expanding role of targeted therapies in patients with gastrointestinal stromal tumor and how these treatments are bolstering later lines of therapy.
Neeta Somaiah, MD
Advertisement
Articles by Neeta Somaiah, MD
Neeta Somaiah, MD, discusses new and upcoming targeted therapies for sarcomas at the Inaugural Miami Cancer Institute Precision Medicine Oncology Symposium.
Neeta Somaiah, MD, reviews the case of a 68-year-old man with gastrointestinal stromal tumor.
Neeta Somaiah, MD, discusses the evolution of treatment options for patients with a unique sarcoma.
Advertisement
Latest Updated Articles
Progressing Gastrointestinal Stromal TumorPublished: July 16th 2020 | Updated:
Treatment Options in Gastrointestinal Stromal TumorsPublished: July 16th 2020 | Updated:
Molecular Testing in Gastrointestinal Stromal TumorsPublished: July 16th 2020 | Updated:
Understanding the INVICTUS TrialPublished: July 16th 2020 | Updated:
Presentation of a Gastrointestinal Stromal Tumor CasePublished: July 16th 2020 | Updated:
Future Directions of Gastrointestinal Stomal TumorsPublished: July 16th 2020 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
